Bio-Reference Laboratories (NASDAQ:BRLI) investors had a great day today, with the stock up 22% after announcing first-quarter earnings. Bio-Reference beat estimates on both the top and bottom lines, although earnings per share still declined year-over-year. Is the company poised to keep succeeding, particularly given the current environment of health care austerity?

In the video below, health care analyst Michael Douglass identifies three key takeaways from the company's earnings report and what investors should be watching for going forward.

Will this stock be your next multi-bagger?
Give us five minutes and we'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Michael Douglass has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.